Visceral Obesity The Link Among Inflammation, Hypertension, and Cardiovascular Disease

被引:351
作者
Mathieu, Patrick [1 ]
Poirier, Paul [4 ]
Pibarot, Philippe [3 ]
Lemieux, Isabelle [2 ]
Despres, Jean-Pierre [2 ]
机构
[1] Univ Laval, Hop Laval, Quebec Heart Inst, Res Ctr,Dept Surg, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Laval, Hop Laval, Quebec Heart Inst, Res Ctr,Div Kinesiol,Dept Social & Prevent Med, Ste Foy, PQ G1V 4G5, Canada
[3] Univ Laval, Hop Laval, Quebec Heart Inst, Res Ctr,Dept Med, Ste Foy, PQ G1V 4G5, Canada
[4] Univ Laval, Hop Laval, Quebec Heart Inst, Res Ctr,Fac Pharm, Ste Foy, PQ G1V 4G5, Canada
关键词
RANDOMIZED CONTROLLED-TRIAL; CORONARY-ARTERY-DISEASE; CANNABINOID-1 RECEPTOR BLOCKER; CARDIOMETABOLIC RISK-FACTORS; TYPE-2; DIABETES-MELLITUS; RENIN-ANGIOTENSIN SYSTEM; HIGH BLOOD-PRESSURE; WEIGHT-LOSS; METABOLIC SYNDROME; ABDOMINAL OBESITY;
D O I
10.1161/HYPERTENSIONAHA.108.110320
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
[No abstract available]
引用
收藏
页码:577 / 584
页数:8
相关论文
共 56 条
[11]   Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia [J].
Despres, JP ;
Golay, A ;
Sjostrom, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2121-2134
[12]   HDL-cholesterol as a marker of coronary heart disease risk:: the Quebec cardiovascular study [J].
Després, JP ;
Lemieux, I ;
Dagenais, GR ;
Cantin, B ;
Lamarche, B .
ATHEROSCLEROSIS, 2000, 153 (02) :263-272
[13]   The sympathetic nervous system and hypertension - Recent developments [J].
DiBona, GF .
HYPERTENSION, 2004, 43 (02) :147-150
[14]   Weight loss and the renin-angiotensin-aldosterone system [J].
Engeli, S ;
Bohnke, J ;
Gorzelniak, K ;
Janke, J ;
Schling, P ;
Bader, M ;
Luft, FC ;
Sharma, AM .
HYPERTENSION, 2005, 45 (03) :356-362
[15]   Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients [J].
Ericsson, CG ;
Hamsten, A ;
Nilsson, J ;
Grip, L ;
Svane, B ;
deFaire, U .
LANCET, 1996, 347 (9005) :849-853
[16]   Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension [J].
Furuhashi, M ;
Ura, N ;
Higashiura, K ;
Murakami, H ;
Tanaka, M ;
Moniwa, N ;
Yoshida, D ;
Shimamoto, K .
HYPERTENSION, 2003, 42 (01) :76-81
[17]   Increased oxidative stress in obesity and its impact on metabolic syndrome [J].
Furukawa, S ;
Fujita, T ;
Shimabukuro, M ;
Iwaki, M ;
Yamada, Y ;
Nakajima, Y ;
Nakayama, O ;
Makishima, M ;
Matsuda, M ;
Shimomura, I .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12) :1752-1761
[18]   INCIDENCE AND PRECURSORS OF HYPERTENSION IN YOUNG-ADULTS - THE FRAMINGHAM OFFSPRING STUDY [J].
GARRISON, RJ ;
KANNEL, WB ;
STOKES, J ;
CASTELLI, WP .
PREVENTIVE MEDICINE, 1987, 16 (02) :235-251
[19]   Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial [J].
Ginsberg, Henry N. ;
Bonds, Denise E. ;
Lovato, Laura C. ;
Crouse, John R. ;
Elam, Marshall B. ;
Linz, Peter E. ;
O'Connor, Patrick J. ;
Leiter, Lawrence A. ;
Weiss, Daniel ;
Lipkin, Edward ;
Fleg, Jerome L. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A) :56I-67I
[20]   Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice [J].
Guo, KY ;
Halo, P ;
Leibel, RL ;
Zhang, YY .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2004, 287 (01) :R112-R119